Pricing Log in Create free account

EyePoint, Inc. (EYPT) vs Nautilus Biotechnology, Inc. (NAUT)

EyePoint, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. EyePoint, Inc. and Nautilus Biotechnology, Inc. are of similar size ($274.9M and $270.7M). Nautilus Biotechnology, Inc. has the higher net margin (0.00% vs −10,998.7%) and the lower return on invested capital (−83.3% vs 0.00%). Across the 13 metrics below, Nautilus Biotechnology, Inc. leads on 9 and EyePoint, Inc. on 4.

Valuation

Metric EYPT NAUT Biotechnology median
P/E n/m n/m 8.50
P/S 93.12 n/m 9.71
P/B 1.56 2.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 40.83 n/m 9.21
Earnings yield (124.67%) (21.84%) (33.15%)
Free cash flow yield (104.43%) (19.80%) (25.50%)

Profitability

Metric EYPT NAUT Biotechnology median
Gross margin 41.75% 0.00% 65.16%
Operating margin (11,369.30%) 0.00% 0.00%
Net margin (10,998.67%) 0.00% 0.00%
Free cash flow margin (9,724.68%) 0.00% 0.00%
Return on equity (148.70%) (36.21%) (56.36%)
Return on assets (115.86%) (30.00%) (48.04%)
Return on invested capital 0.00% (83.32%) 0.00%

Growth

Metric EYPT NAUT Biotechnology median
Revenue growth (TTM) (94.63%) — 6.02%
EPS growth (last fiscal year) (36.64%) 16.07% 30.26%
Revenue growth, 5-year CAGR (1.85%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EYPT NAUT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.50 10.14 4.72
Net debt to EBITDA 1.24 1.67 0.96

Dividend

Metric EYPT NAUT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EYPT NAUT Biotechnology median
Market cap 270.71m 274.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack